Early research suggests transdermal GLP-1 delivery may provide consistent hormone levels, though clinical efficacy varies significantly based on individual biomarkers, baseline metabolic health, and adherence patterns
Vasc Health Risk Manag 4(1):143156 Acknowledgements We thank the patients who participated in the present study, for their cooperation, time, and patience
doi: 10.1093/annonc/mdx079 152 WoodmanSEDaviesMA
Park, S.H
Compounded Medication Notice: Compounded medications, including compounded GLP-1 agonists, are not FDA reviewed for safety, effectiveness, or manufacturing
The remaining Glucose-stimulated insulin secretion (GSIS) appears to be enhanced by nutrients, hormones such as CCK, bile acids and endogenous ethanolamides